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SUMMARY
Trichosporon spp. are yeasts capable of causing invasive disease, which mainly affect immunocompromised patients. A clinical 
strain of T. asahii was isolated from the blood cultures of patients admitted to the General Hospital of Fortaleza. Susceptibility tests 
were conducted by disk diffusion and broth microdilution. The isolated strain of T. asahii was resistant to fluconazole. The patient 
used amphotericin B and caspofungin in order to facilitate the microbiological cure. It was the first isolation and identification of T. 
asahii in blood culture in Ceará, Brazil.
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INTRODUCTION
Trichosporon are yeasts that belong to the basidiomycetes group, and 
may be found to be present in the external environment, primarily in the 
soil, but also in water, air, and organic substrates. The use of molecular 
biological techniques has led to the reorganization of the genus, with a 
proposed new classification that consists of 17 species and five varieties13. 
T. asahii and T. mucoides are associated with deep infections, while T. 
asteroides, T. ovoides and T. cutaneum are responsible for white piedra 
and other superficial infections. T. inkin is responsible for both superficial 
and deep infections, and cases of infection with T. pullulans have recently 
been reported1.
T. asahii is part of the cutaneous fungal microbiota present in humans. 
T. asahii of cutaneous origin may be one of the principal ways through 
which deep-seated trichosporonosis is acquired, whereas T. asahii taken 
from its natural environment is not associated with this infection15.
At present, there is little data on the susceptibility of T. asahii to 
antifungal agents. The fungus is known to exhibit variable susceptibility to 
amphotericin B (MIC 0.01 to 4 μg/mL), and some studies revealed relative 
resistance to this agent4. The triazoles exhibit greater in-vitro activity 
when compared with amphotericin B, and some authors recommend 
combined treatment with the latter. Other in-vitro studies reported greater 
fungicidal action by triazoles such as voriconazole, posaconazole and 
ravuconazole11.
Reports of isolation of T. asahii from blood cultures are rare11, in 
Ceará they are unknown. Very little is known about the susceptibility 
of these strains - mainly to fluconazole. The aim of this study was to 
isolate, identify and determine the susceptibility profile of one strain of 
Trichosporon spp isolated from a blood culture at the General Hospital 
of Fortaleza.
MATERIALS AND METHODS
The A.M.N. patient, male, 31 years old, underlying acute myeloid 
leukemia; had a fever and nosocomial infection, was a neutropenic, 
used chemotherapy drugs and antibiotics (rifampicin, imipenem and 
vancomycin), had a negative blood culture for bacteria and therefore 
used a prophylactic fluconazole. The patient underwent a chest drain, 
which was probably the source of the contamination. The blood sample 
was sent to the Laboratory, inoculated on potato dextrose agar and left 
to be incubated at 35 °C for 24 hours. T. asahii was isolated in three 
collections. The following indicators were used for identification: an 
API 20C AUX® kit for yeast identification (BioMérieux, Marcy-l’Étoile, 
France), fermentation and carbohydrate assimilation, susceptibility to 
cycloheximide, capacity for growth at different temperatures, growth 
in a chromogenic medium and micromorphology on a medium of rice 
agar Tween-80. The chromogenic medium was used for preliminary 
identification. Testing was carried out on a rice agar Tween-80, and we 
observed: the production of true hyphae with rectangular arthroconidia 
and the absence of appressoria that are characteristic of this species. This 
was additionally done with sugar assimilation tests.
The susceptibility of the T. asahii strain was evaluated by the disk 
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diffusion method, in accordance with protocol M44-A of the Clinical and 
Laboratory Standards Institute (CLSI). Susceptibility to fluconazole and 
amphotericin B was also assessed through the broth microdilution method 
(protocol M27-A3) using RPMI, with the concentration of fluconazole 
ranging from 64 to 0.25 μg/mL, and the concentration of amphotericin B 
ranging from 16 to 0.03 μg/mL2,3,9. The strain was classified according to 
the inhibition halos on the discs: halo >19 mm (susceptible (S)); 14-19 
mm (dose-dependent susceptible (DDS)); and < 14 mm (resistant (R))6,9,12. 
To test the microdilution for fluconazole, the breakpoints were: MIC 
susceptible ≤ 8 μg/mL; DDS = 16-32 μg/mL and resistant > 64 μg/mL; 
for amphotericin B: MIC susceptible ≤ 1 μg/mL; MIC resistant > 1 μg/
mL. The test for each sample was repeated twice. The strains Candida 
albicans ATCC 10231, C. albicans ATCC 14053 and C. parapsilosis 
ATCC 22019 were all used as controls.
RESULTS AND DISCUSSION
Disseminated trichosporonosis is a severe opportunistic mycosis and 
has a high mortality rate. However, the clinical features of the patients 
with Trichosporon and Candida could not be distinguished. The overall 
in-hospital mortality rate of trichosporonosis was 56.1%8. In our study, 
the patient survived. The probable cause of infection was invasive medical 
procedures, however no epidemiological studies were undertaken to 
discover the origin from T. asahii.
The T. asahii strain was resistant to fluconazole by the disk diffusion 
and microdilution method with halo = 10 mm and MIC > 64 μg/mL 
respectively, and exhibited susceptibility to amphotericin B with 
halo = 14 mm and MIC = 0.06 μg/mL. When infected with T. asahii, 
immunocompromised patients can have a poor prognosis, and it is 
essential to identify and determine the susceptibility profile of the strain 
for the application of the appropriate therapy5.
The therapeutic response to new azoles such as voriconazole is quite 
promising. In a study of 101 strains of T. asahii isolated in Thailand, a 
low susceptibility to fluconazole and amphotericin B was observed, and 
voriconazole represented the best alternative8. In a study of 26 strains 
of T. asahii, high resistance to fluconazole was observed10. There is 
little data available regarding T. asahii’s susceptibility to antifungal 
drugs in Brazil. The emergence of T. asahii with reduced susceptibility 
to common antifungal drugs is cause for concern14. In our study, 
resistance to fluconazole was detected, but the strain was susceptible to 
amphotericin B.
Recent studies demonstrate a synergy between caspofungin and 
amphotericin B. However, it is difficult to explain how the echinocandin 
MICs are lowered when the drug is together with amphotericin B7. In 
our study, the patient used amphotericin B together with caspofungin 
and was cured of the fungal infection. Caspofungin was used for 12 
days and amphotericin was used for nine days and the T. asahii culture 
turned negative.
The most common underlying conditions related to trichosporonosis 
were hematological diseases, peritoneal dialysis and solid tumor. 
Trichosporonemia occurred in 115 out of the 154 (74.7%) patients and 
disseminated infection occurred in 78 out of the 154 (50.6%) cases. The 
majority of cases of trichosporonosis were reported in North American 
medical centers (33.9%), followed by Europe (27.6%) and Asia (23.3%). 
Only six cases were reported in South American institutions, including 
five cases in Brazil and one case in Argentina1. There are no studies 
on the cases and identification of T. asahii in blood cultures in Ceará, 
Brazil. Further studies with a higher number of strains may assist in 
understanding the mechanisms of resistance of this yeast.
RESUMO
Isolamento e teste de susceptibilidade aos antifúngicos de 
Trichosporon asahii no Ceará, Brasil
Trichosporon spp. são leveduras capazes de causar doença invasiva, 
que afetam principalmente pacientes imunocomprometidos. Uma cepa 
clínica de T. asahii foi isolada em hemocultura de paciente internado no 
Hospital Geral de Fortaleza. Os testes de suscetibilidade foram realizados 
por difusão em disco e microdiluição em caldo. A cepa isolada do T. 
asahii foi resistente ao fluconazol, o paciente fez uso de anfotericina 
B e caspofungina então a cura microbiológica ocorreu. Foi o primeiro 
isolamento e identificação de T. asahii em hemocultura no Ceará,Brasil.
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